Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and DIS3L2

40Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Perlman syndrome is a rare autosomal recessively inherited congenital overgrowth syndrome characterized by polyhydramnios, macrosomia, characteristic facial dysmorphology, renal dysplasia and nephroblastomatosis and multiple congenital anomalies. Perlman syndrome is associated with high neonatal mortality and, survivors have developmental delay and a high risk of Wilms tumor. Recently a Perlman syndrome locus was mapped to chromosome 2q37 and homozygous or compound heterozygous mutations were characterized in DIS3L2. The DIS3L2 gene product has ribonuclease activity and homology to the DIS3 component of the RNA exosome. It has been postulated that the clinical features of Perlman syndrome result from disordered RNA metabolism and, though the precise targets of DIS3L2 have yet to be characterized, in cellular models DIS3L2 knockdown is associated with abnormalities of cell growth and division. © 2013 Wiley Periodicals, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Morris, M. R., Astuti, D., & Maher, E. R. (2013). Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and DIS3L2. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 163(2), 106–113. https://doi.org/10.1002/ajmg.c.31358

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free